Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Merck: High Upside Expected From Vaccine
Seeking Alpha
Wednesday, April 4, 2012 - 8:32am
tags:
Merck, vaccines, shingles, Zostavax, herpes zoster
Watch Achillion Pharmaceuticals For Upcoming Phase IIa Data
Seeking Alpha
Wednesday, April 4, 2012 - 8:30am
tags:
Achillion, hepatitis C, ACH-1625
Glaxo, Pfizer Suit Claims Hikma Infringes Argatroban Patent
Bloomberg
Wednesday, April 4, 2012 - 8:29am
tags:
GSK, patents, Argatroban, Pfizer, Hikma
FDA's Expanded Intelence Approval Will Boost JNJ's Anti-Infectives Business
Forbes
Wednesday, April 4, 2012 - 8:29am
tags:
FDA, Intelence, anti-infectives, JNJ, non-nucleoside reverse transcriptase inhibitor
Keryx: Few Options After Failed Trial
Seeking Alpha
Wednesday, April 4, 2012 - 8:27am
tags:
Keryx, Aeterna Zentaris, perifosine, colorectal cancer
Roche, Illumina at Stalemate Ahead of Shareholder Meeting
WSJ Online
Tuesday, April 3, 2012 - 11:16am
tags:
Roche, Illumina, M&A
Celgene's Compelling Growth Story
Seeking Alpha
Tuesday, April 3, 2012 - 11:12am
tags:
Celgene
More States Spank High-Prescribing Docs
Pharmalot
Tuesday, April 3, 2012 - 10:18am
tags:
physicians, Medicaid, antipsychotics, oxycontin
AMRI Signs Exclusive Option to License its Tubulin Inhibitor Program for Cancer
CP Wire
Tuesday, April 3, 2012 - 10:14am
tags:
tubulin inhibitor, AMRI
Onyx Pharma: Phase 3 trial of Regorafenib meets primary endpoint for GIST
Yahoo/Fly on the Wall
Tuesday, April 3, 2012 - 10:12am
tags:
ONYX Pharmaceuticals, regorafenib, GIST, Bayer
Amylin completes application to FDA for metreleptin
Yahoo/Fly on the Wall
Tuesday, April 3, 2012 - 10:10am
tags:
FDA, metreleptin, Amylin, lipodystrophy
Agenus: Buy Or Ready To Bust?
Seeking Alpha
Tuesday, April 3, 2012 - 9:01am
tags:
Agenus, glioma, Prophage
Roche says disappointed by Illumina bid rejection
Reuters
Tuesday, April 3, 2012 - 9:00am
tags:
M&A, Roche, Illumina
3 Anti-Obesity Drug Companies Poised To Grow
Seeking Alpha
Tuesday, April 3, 2012 - 8:59am
tags:
obesity, Vivus, Orexigen, lorcaserin, Arena Pharmaceuticals, Contrave, Qnexa
Another Option Strategy For Vivus
Seeking Alpha
Tuesday, April 3, 2012 - 8:58am
tags:
Vivus, options
Bayer Says Drug Held Off Gastrointestinal Tumors in Study
Bloomberg
Tuesday, April 3, 2012 - 8:57am
tags:
gastrointestinal cancer, Bayer, regorafenib
Map Pharmaceuticals: The Levadex Levitation
Seeking Alpha
Tuesday, April 3, 2012 - 8:56am
tags:
MAP Pharmaceuticals, Levadex, Allergan, migraines
Astellas Overactive Bladder Drug Raises Risks, FDA Staff Says
Bloomberg
Tuesday, April 3, 2012 - 8:54am
tags:
Astellas, overactive bladder, FDA, mirabegron
Astex Pharmaceuticals announces positive clinical data for SGI-110
The Fly on the Wall
Tuesday, April 3, 2012 - 8:53am
tags:
SGI-110, Astex, AML, acute myeloid leukemia
J&J Alzheimer’s Drug May Cut Brain Chemical Tied to Tangles
Bloomberg
Monday, April 2, 2012 - 7:25pm
tags:
Alzheimer's disease, JNJ, bapineuzumab

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.